Syracuse, NY · Founded 2015 · Privately Held (backing)
Developer of a small molecule-based osteoinductive technology designed to suspend cancer, inhibit pain and regenerate bone. ZetaGen Therapeutics is based in Syracuse, NY and was founded in 2015. It was valued at $180 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $52.5 million across 4 recorded rounds; the latest was a $12.9 million early-stage round in Jan 2025.
PMV mark · valuation
$180.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$52.5M
Last round
Early Stage VC
Jan 2025
Team — not yet on record
No current team members for ZetaGen Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ZetaGen Therapeutics with a free account
·Watch ZetaGen Therapeutics: the Monday email on marks, rounds and moves
